Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 1091 results

Search term: MF = 'C_{26}H_{30}ClN_{5}O_{3}'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
64704
InChI=1/C19H23NO.C7H7ClN4O2/c1-20-14-12-18(13-15-20)21-19(16-8-4-2-5-9-16)17-10-6-3-7-11-17;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h2-11,18-19H,12-15H2,1H3;1-2H3,(H,9,10)
C26H30ClN5O3496.0011303401
2490257
InChI=1/C26H30ClN5O3/c27-21-6-3-7-22(17-21)31-15-13-30(14-16-31)11-4-10-28-24(33)18-29-25(34)19-32-12-9-20-5-1-2-8-23(20)26(32)35/h1-3,5-9,12,17H,4,10-11,13-16,18-19H2,(H,28,33)(H,29,34)
C26H30ClN5O3496.0011151100
2491377
InChI=1/C26H30ClN5O3/c27-21-5-3-6-22(18-21)31-16-14-30(15-17-31)13-11-29-24(33)8-10-28-25(34)19-32-12-9-20-4-1-2-7-23(20)26(32)35/h1-7,9,12,18H,8,10-11,13-17,19H2,(H,28,34)(H,29,33)
C26H30ClN5O3496.0011131000
3630644

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClN5O3/c1-19(16-26(35)31-13-11-30(12-14-31)22-7-4-6-21(27)17-22)15-24(33)28-29-25(34)18-32-10-9-20-5-2-3-8-23(20)32/h2-10,17,19H,11-16,18H2,1H3,(H,28,33)(H,29,34)
C26H30ClN5O3496.001113900
20284855
InChI=1/C26H30ClN5O3/c1-18(2)35-17-5-16-31-25(34)21-6-3-4-7-22(21)32-23(29-30-26(31)32)12-13-24(33)28-15-14-19-8-10-20(27)11-9-19/h3-4,6-11,18H,5,12-17H2,1-2H3,(H,28,33)
C26H30ClN5O3496.001112900
29038645
InChI=1/C26H30ClN5O3/c1-16(2)11-12-30-24(34)20-10-9-18(23(33)28-14-17(3)4)13-22(20)32-25(30)29-31(26(32)35)15-19-7-5-6-8-21(19)27/h5-10,13,16-17H,11-12,14-15H2,1-4H3,(H,28,33)
C26H30ClN5O3496.0011121000
29038647
InChI=1/C26H30ClN5O3/c1-16(2)10-11-30-24(34)21-9-8-19(23(33)28-14-17(3)4)13-22(21)32-25(30)29-31(26(32)35)15-18-6-5-7-20(27)12-18/h5-9,12-13,16-17H,10-11,14-15H2,1-4H3,(H,28,33)
C26H30ClN5O3496.0011111000
29038599

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClN5O3/c1-5-17(4)28-23(33)18-10-11-20-22(14-18)32-25(30(24(20)34)13-12-16(2)3)29-31(26(32)35)15-19-8-6-7-9-21(19)27/h6-11,14,16-17H,5,12-13,15H2,1-4H3,(H,28,33)
C26H30ClN5O3496.0011111000
29038600

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClN5O3/c1-5-17(4)28-23(33)19-8-11-21-22(14-19)32-25(30(24(21)34)13-12-16(2)3)29-31(26(32)35)15-18-6-9-20(27)10-7-18/h6-11,14,16-17H,5,12-13,15H2,1-4H3,(H,28,33)
C26H30ClN5O3496.0011111000
22186751
InChI=1/C26H30ClN5O3/c27-16-7-10-21-22(13-16)31-23(30-21)11-12-28-25(34)19-14-32(18-8-9-18)15-20(24(19)33)26(35)29-17-5-3-1-2-4-6-17/h7,10,13-15,17-18H,1-6,8-9,11-12H2,(H,28,34)(H,29,35)(H,30,31)
C26H30ClN5O3496.0011111000
13149099
InChI=1/C26H30ClN5O3/c1-5-31(6-2)15-9-14-28-25(33)23-22-18-10-7-8-11-20(18)30(3)24(22)26(34)32(29-23)17-12-13-21(35-4)19(27)16-17/h7-8,10-13,16H,5-6,9,14-15H2,1-4H3,(H,28,33)
C26H30ClN5O3496.001111900
13149143
InChI=1/C26H30ClN5O3/c1-5-6-14-30(2)15-13-28-25(33)23-22-18-9-7-8-10-20(18)31(3)24(22)26(34)32(29-23)17-11-12-21(35-4)19(27)16-17/h7-12,16H,5-6,13-15H2,1-4H3,(H,28,33)
C26H30ClN5O3496.001111900
2480422

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClN5O3/c1-26(2,3)32-25(28-29-30-32)24(19-10-13-22(33-4)23(15-19)34-5)31(17-21-7-6-14-35-21)16-18-8-11-20(27)12-9-18/h6-15,24H,16-17H2,1-5H3
C26H30ClN5O3496.001111600
18461413
InChI=1/C26H29N5O3.ClH/c1-32-20-6-4-7-21(18-20)34-17-15-30-11-13-31(14-12-30)26-28-24-10-3-2-9-23(24)25(29-26)27-19-22-8-5-16-33-22;/h2-10,16,18H,11-15,17,19H2,1H3,(H,27,28,29);1H
C26H30ClN5O3496.001110800
21359407
InChI=1/C26H30ClN5O3/c1-35-20-5-3-19(4-6-20)30-12-14-31(15-13-30)25(33)8-10-28-26(34)32-11-9-21-22-16-18(27)2-7-23(22)29-24(21)17-32/h2-7,16,29H,8-15,17H2,1H3,(H,28,34)
C26H30ClN5O3496.001110800
2095353

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClN5O3/c27-22-8-6-20(7-9-22)23(18-30-10-14-34-15-11-30)24-26(33)32(19-31-12-16-35-17-13-31)29-25(28-24)21-4-2-1-3-5-21/h1-9,23H,10-19H2
C26H30ClN5O3496.001110800
2095355

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C26H30ClN5O3/c27-23-9-5-4-8-21(23)22(18-30-10-14-34-15-11-30)24-26(33)32(19-31-12-16-35-17-13-31)29-25(28-24)20-6-2-1-3-7-20/h1-9,22H,10-19H2
C26H30ClN5O3496.001110800
22859013

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C26H30ClN5O3/c1-3-18-7-9-20(10-8-18)15-31-16-22(32-17-23(29-30-32)26(34)35-2)14-24(31)25(33)28-12-11-19-5-4-6-21(27)13-19/h4-10,13,17,22,24H,3,11-12,14-16H2,1-2H3,(H,28,33)/t22-,24-/m0/s1
C26H30ClN5O3496.001110900
22859526

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C26H30ClN5O3/c1-35-26(34)23-18-32(30-29-23)22-16-24(25(33)28-13-12-20-9-5-11-21(27)15-20)31(17-22)14-6-10-19-7-3-2-4-8-19/h2-5,7-9,11,15,18,22,24H,6,10,12-14,16-17H2,1H3,(H,28,33)/t22-,24+/m1/s1
C26H30ClN5O3496.001110900
22867767

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C26H30ClN5O3/c1-17-7-8-20(18(2)11-17)14-31-15-22(32-16-23(29-30-32)26(34)35-3)13-24(31)25(33)28-10-9-19-5-4-6-21(27)12-19/h4-8,11-12,16,22,24H,9-10,13-15H2,1-3H3,(H,28,33)/t22-,24-/m0/s1
C26H30ClN5O3496.001110900
12345

Advertisement